120 related articles for article (PubMed ID: 8189662)
21. A risk-adapted strategy of radiotherapy or cisplatin-based chemotherapy in stage II seminoma.
Domont J; Massard C; Patrikidou A; Bossi A; de Crevoisier R; Rose M; Wibault P; Fizazi K
Urol Oncol; 2013 Jul; 31(5):697-705. PubMed ID: 21665493
[TBL] [Abstract][Full Text] [Related]
22. [The clinical treatment analysis of 176 cases of testicular germ cell tumor].
Zhang P; Zeng H; Lu YP; Yuan Y; Li H
Zhonghua Nan Ke Xue; 2006 Mar; 12(3):237-9. PubMed ID: 16597041
[TBL] [Abstract][Full Text] [Related]
23. [Long-term outcome of testicular seminoma in 294 patients].
Song Y; Yang L; Ma JH; Liu XF; Wang JW
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):626-9. PubMed ID: 19102945
[TBL] [Abstract][Full Text] [Related]
24. Stage II testicular seminoma: patterns of recurrence and outcome of treatment.
Chung PW; Gospodarowicz MK; Panzarella T; Jewett MA; Sturgeon JF; Tew-George B; Bayley AJ; Catton CN; Milosevic MF; Moore M; Warde PR
Eur Urol; 2004 Jun; 45(6):754-59; discussion 759-60. PubMed ID: 15149748
[TBL] [Abstract][Full Text] [Related]
25. Testicular germ cell tumors in patients with human immunodeficiency virus infection.
Hentrich MU; Brack NG; Schmid P; Schuster T; Clemm C; Hartenstein RC
Cancer; 1996 May; 77(10):2109-16. PubMed ID: 8640678
[TBL] [Abstract][Full Text] [Related]
26. [Treatment and prognosis of stage II testicular seminoma].
Li Y; Qian T; Yu Z
Zhonghua Zhong Liu Za Zhi; 1995 Mar; 17(2):142-5. PubMed ID: 7656808
[TBL] [Abstract][Full Text] [Related]
27. Clinical Characteristics and Outcomes of Late Relapse in Stage I Testicular Seminoma.
Hosni A; Warde P; Jewett M; Bedard P; Hamilton R; Moore M; Nayan M; Huang R; Atenafu EG; O'Malley M; Sweet J; Chung P
Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):648-54. PubMed ID: 27339401
[TBL] [Abstract][Full Text] [Related]
28. Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer.
Pizzocaro G; Salvioni R; Pasi M; Zanoni F; Milani A; Pilotti S; Monfardini S
Cancer; 1985 Jul; 56(2):249-55. PubMed ID: 2408728
[TBL] [Abstract][Full Text] [Related]
29. Pitfalls in the interpretation of specimens from patients with testicular tumours, with an emphasis on variant morphologies.
Ulbright TM
Pathology; 2018 Jan; 50(1):88-99. PubMed ID: 29129333
[TBL] [Abstract][Full Text] [Related]
30. The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma.
Hinz S; Schrader M; Kempkensteffen C; Bares R; Brenner W; Krege S; Franzius C; Kliesch S; Heicappel R; Miller K; de Wit M
J Urol; 2008 Mar; 179(3):936-40; discussion 940. PubMed ID: 18207171
[TBL] [Abstract][Full Text] [Related]
31. Sequential resection of residual abdominal and thoracic masses after chemotherapy for metastatic non-seminomatous germ cell tumours.
Gerl A; Clemm C; Schmeller N; Dienemann H; Weiss M; Kriegmair M; Löhrs U; Wilmanns W
Br J Cancer; 1994 Nov; 70(5):960-5. PubMed ID: 7524606
[TBL] [Abstract][Full Text] [Related]
32. Extracranial non-testicular teratoma in childhood and adolescence: introduction of a risk score for stratification of therapy.
Göbel U; Calaminus G; Blohm M; Booss D; Felberbauer F; Hofmann U; Holschneider AM; Willnow U; Harms D
Klin Padiatr; 1997; 209(4):228-34. PubMed ID: 9293455
[TBL] [Abstract][Full Text] [Related]
33. [Clinical statistics of germinal testicular cancer].
Seguchi T; Iwasaki A; Sugao H; Nakano E; Matsuda M; Sonoda T
Nihon Hinyokika Gakkai Zasshi; 1990 Jun; 81(6):889-94. PubMed ID: 2402112
[TBL] [Abstract][Full Text] [Related]
34. The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary.
Géczi L; Gomez F; Bak M; Bodrogi I
J Cancer Res Clin Oncol; 2003 May; 129(5):309-15. PubMed ID: 12748851
[TBL] [Abstract][Full Text] [Related]
35. Late relapse of stage I testicular seminoma metastatic to just a para-ureteropelvic region.
Tadokoro M; Masuda H; Fujii Y; Kobayashi T; Kageyama Y; Kihara K
Int J Urol; 2004 Nov; 11(11):1044-6. PubMed ID: 15509217
[TBL] [Abstract][Full Text] [Related]
36. Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group.
Tandstad T; Smaaland R; Solberg A; Bremnes RM; Langberg CW; Laurell A; Stierner UK; Ståhl O; Cavallin-Ståhl EK; Klepp OH; Dahl O; Cohn-Cedermark G
J Clin Oncol; 2011 Feb; 29(6):719-25. PubMed ID: 21205748
[TBL] [Abstract][Full Text] [Related]
37. The importance of prognostic factors in the individual treatment of patients with disseminated germ cell tumours.
Mulders PF; Oosterhof GO; Boetes C; de Mulder PH; Theeuwes AG; Debruyne FM
Br J Urol; 1990 Oct; 66(4):425-9. PubMed ID: 2224438
[TBL] [Abstract][Full Text] [Related]
38. [Testicular seminoma in stages I and II non-bulky. 16 years' experience].
Maranzano E; Latini P; Leggio M; Aristei C; Panizza BM; Perrucci E; Lupattelli M
Radiol Med; 1994 Jun; 87(6):865-9. PubMed ID: 8041942
[TBL] [Abstract][Full Text] [Related]
39. The pattern of spread and treatment of metastases in testicular seminoma.
Calman FM; Peckman MJ; Hendry WF
Br J Urol; 1979 Apr; 51(2):154-60. PubMed ID: 465975
[TBL] [Abstract][Full Text] [Related]
40. [Clinical observation of twelve cases of testicular cancer].
Takemae K; Tajiri S; Suzuki T; Hata S
Hinyokika Kiyo; 1987 Aug; 33(8):1199-206. PubMed ID: 2447765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
